APA (7th ed.) Citation

Corwin A. Robertson, Jeffry Jacqmein, Alexandre Selmani, Katherine Galarza, & Philipp Oster. (2023). Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Corwin A. Robertson, Jeffry Jacqmein, Alexandre Selmani, Katherine Galarza, and Philipp Oster. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered as a Booster to Adults Aged ≥59 Years: A Phase III Randomized Study. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Corwin A. Robertson, et al. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered as a Booster to Adults Aged ≥59 Years: A Phase III Randomized Study. Taylor & Francis Group, 2023.